Memphasys Company Description

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

The company primarily develops Felix, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes.

It also provides RoXsta, a rapid oxidative stress assay; and AI-Port. In addition, the company offers ambient temperature storage product for human sperm.

Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.

Memphasys Limited

Country	Australia
Founded	2006
Industry	Biotechnology
Sector	Healthcare
Employees	24
CEO	David Ali

Contact Details

Address: 34 Richmond Road Homebush, New South Wales 2140 Australia
Phone	61 2 8415 7300
Website	memphasys.com

Stock Details

Ticker Symbol	MEM
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000MEM5
SIC Code	2836

Key Executives

Name	Position
Dr. David Ali	Chief Executive Officer, MD and Executive Director
Pablo Neyertz	Director of Finance
Associate Prof. Hassan Bakos	Director of Operations
Prof. R. John Aitken Ph.D., ScD FRSE	Scientific Director
Andrew William Metcalfe B.Bus., C.P.A., CPA, DipAppCorpGov, FCIS, FGIA, MA	Company Secretary